Patents Assigned to DIOSynVax Ltd
  • Patent number: 12691172
    Abstract: Designed coronavirus polypeptide sequences are described, and their use as vaccines against viruses of the coronavirus family. The designed sequences include designed coronavirus spike(S) proteins and fragments thereof, including designed S protein receptor binding domain (RBD) sequence SEQ ID NO:17, designed truncated S protein sequence SEQ ID NO:15, and designed full length S protein sequence SEQ ID NO:13. Designed coronavirus envelope (E), membrane (M), and nucleocapsid (N) protein sequences are also described, and their use as vaccines. Nucleic acid molecules encoding the polypeptides, vectors, fusion proteins, pharmaceutical compositions, cells, and their use as vaccines against viruses of the coronavirus family are also described.
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: July 28, 2026
    Assignees: DIOSynVax Ltd, Cambridge Enterprise Limited
    Inventors: Jonathan Luke Heeney, Sneha Vishwanath, George William Carnell, David Wells, Matteo Ferrari